相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Elevated serum expression of p53 and association of TP53 codon 72 polymorphisms with risk of cervical cancer in Bangladeshi women
Md Shaki Mostaid et al.
PLoS One (2021)
Prevalence of Sarcopenia and Its Association With Diabetes: A Meta-Analysis of Community-Dwelling Asian Population
Seung Min Chung et al.
FRONTIERS IN MEDICINE (2021)
Genetic polymorphisms of TP53 (rs1042522) and MDM2 (rs2279744) and colorectal cancer risk: An updated meta-analysis based on 59 case-control studies
Rami M. Elshazli et al.
GENE (2020)
Association of TP53 rs1042522 with cervical cancer in the sub-Saharan African population: a meta-analysis
Abram Bunya Kamiza et al.
TROPICAL MEDICINE & INTERNATIONAL HEALTH (2020)
TP53 genetic polymorphisms and susceptibility to cervical cancer in Bangladeshi women: a case-control study
Mohd Nazmul Hasan Apu et al.
MOLECULAR BIOLOGY REPORTS (2020)
Interaction between TP53 and XRCC1 increases susceptibility to cervical cancer development: a case control study
Gui-Cen Liu et al.
BMC CANCER (2019)
Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
Freddie Bray et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2018)
Genetic Predisposition to Cervical Cancer and the Association With XRCC1 and TGFB1 Polymorphisms
Najla M. Al-Harbi et al.
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER (2017)
Trial Sequential Analysis in systematic reviews with meta-analysis
Jorn Wetterslev et al.
BMC MEDICAL RESEARCH METHODOLOGY (2017)
Combined analysis of pri-miR-34b/c rs4938723 and TP53 Arg72Pro with cervical cancer risk
Fang Yuan et al.
TUMOR BIOLOGY (2016)
Global Cancer Statistics, 2012
Lindsey A. Torre et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2015)
Murine Double-Minute 2 Homolog Single Nucleotide Polymorphisms 285 and 309 in Cervical Carcinogenesis
Andrzej Roszak et al.
MOLECULAR DIAGNOSIS & THERAPY (2015)
Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012
Jacques Ferlay et al.
INTERNATIONAL JOURNAL OF CANCER (2015)
The preliminary study of p53 codon 72 polymorphism and risk of cervical carcinoma in Gabonese women
Samira Zoa Assoumou et al.
MEDICAL ONCOLOGY (2015)
Impact of TP53 Codon 72 and MDM2 SNP 309 Polymorphisms in Pancreatic Ductal Adenocarcinoma
Yasuki Hori et al.
PLOS ONE (2015)
Effects of MDM2 promoter polymorphisms on the development of cervical neoplasia in a Southeastern Brazilian population
Sandra Liliana Vargas-Torres et al.
BIOMARKERS (2014)
Association of TP53 codon 72 and intron 3 16-bp Ins/Del polymorphisms with cervical cancer risk
Tatiana Dantas Rodrigues Laprano et al.
TUMOR BIOLOGY (2014)
MTHFR/p53 polymorphisms as genetic factors for cervical intraepithelial neoplasia and cervical cancer in HPV-infected Mexican women
Lizbeth Gonzalez-Herrera et al.
INTERNATIONAL JOURNAL OF BIOLOGICAL MARKERS (2014)
TP53 codon 72 polymorphism and risk of cervical carcinoma in Serbian women
Emina Malisic et al.
ARCHIVES OF GYNECOLOGY AND OBSTETRICS (2013)
Association of MDM2 and p53 Polymorphisms with the Advancement of Cervical Carcinoma
Pallavi Singhal et al.
DNA AND CELL BIOLOGY (2013)
HPV prevalence and genetic predisposition to cervical cancer in Saudi Arabia
Ghazi Alsbeih et al.
INFECTIOUS AGENTS AND CANCER (2013)
Contribution of retinoblastoma LOH and the p53 Arg/Pro polymorphism to cervical cancer
Huda A. Eltahir et al.
MOLECULAR MEDICINE REPORTS (2012)
The effect of TP53 codon 72 and RNASEL codon 462 polymorphisms on the development of cervical cancer in Argentine women
Gisela Barbisan et al.
CANCER GENETICS (2011)
Role of p53 and p21 polymorphisms in the risk of cervical cancer among Chinese women
Pei Jiang et al.
ACTA BIOCHIMICA ET BIOPHYSICA SINICA (2010)
Effect of MDM2 SNP309 and p53 codon 72 polymorphisms on lung cancer risk and survival among non-smoking Chinese women in Singapore
Hui Wan Chua et al.
BMC CANCER (2010)
A High-Frequency Regulatory Polymorphism in the p53 Pathway Accelerates Tumor Development
Sean M. Post et al.
CANCER CELL (2010)
p53 Codon 72 polymorphism is associated with occurrence of cervical carcinoma in the Chinese population
Feng Ye et al.
CANCER LETTERS (2010)
MDM2 SNP 309 human papillomavirus infection in cervical carcinogenesis
Osamu Nunobiki et al.
GYNECOLOGIC ONCOLOGY (2010)
Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008
Jacques Ferlay et al.
INTERNATIONAL JOURNAL OF CANCER (2010)
p53 Codon 72 and p21 Codon 31 Polymorphisms and Susceptibility to Cervical Adenocarcinoma in Korean Women
Ju-Won Roh et al.
ONCOLOGY RESEARCH (2010)
TP53 Mutations in Human Cancers: Origins, Consequences, and Clinical Use
Magali Olivier et al.
COLD SPRING HARBOR PERSPECTIVES IN BIOLOGY (2010)
Polymorphisms in HPV E6/E7 protein interacted genes and risk of cervical cancer in Chinese women: A case-control analysis
Xiaoyi Zhou et al.
GYNECOLOGIC ONCOLOGY (2009)
Polymorphisms of p53 codon 72 and MDM2 promoter 309 and the risk of endometrial cancer
Osamu NUNOBIKI et al.
Human Cell (2009)
Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement
David Moher et al.
BMJ-BRITISH MEDICAL JOURNAL (2009)
MDM2 and p53 polymorphisms are associated with the development of hepatocellular carcinoma in patients with chronic hepatitis B virus infection
Young Joon Yoon et al.
CARCINOGENESIS (2008)
Ethnicity determines association of p53Arg72Pro alleles with cervical cancer in China
Xing-Zheng Zheng et al.
EUROPEAN JOURNAL OF CANCER PREVENTION (2008)
TP53 mutations in human cancers:: functional selection and impact on cancer prognosis and outcomes
A. Petitjean et al.
ONCOGENE (2007)
No association between SNP309 promoter polymorphism in the MDM2 and cervical cancer in a study from northeastern Brazil
Rosely de Vasconcellos Meissner et al.
CANCER DETECTION AND PREVENTION (2007)
Human papillomavirus and p53 polymorphism in Lithuanian cervical cancer patients
Zivile Gudleviciene et al.
GYNECOLOGIC ONCOLOGY (2006)
Genetic polymorphisms in cell cycle regulatory genes MDM2 and TP53 are associated with susceptibility to lung cancer
XM Zhang et al.
HUMAN MUTATION (2006)
TP53 codon 72 polymorphism and risk for cervical cancer in Portugal
AM Santos et al.
CANCER GENETICS AND CYTOGENETICS (2005)
Genetic polymorphisms of p73 G4C14-to-A4T14 at exon 2 and p53 Arg72Pro and the risk of cervical cancer in Japanese
Y Niwa et al.
CANCER LETTERS (2004)
p53 polymorphic variants at codon 72 exert different effects on cell cycle progression
D Pim et al.
INTERNATIONAL JOURNAL OF CANCER (2004)
A single nucleotide polymorphism in the MDM2 promoter attenuates the p53 tumor suppressor pathway and accelerates tumor formation in humans
GL Bond et al.
CELL (2004)
Gene-gene and gene-environmental interactions of p53, p21, and IRF-1 polymorphisms in Korean women with cervix cancer
JE Lee et al.
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER (2004)
The utility of single nucleotide polymorphisms in inferences of population history
RT Brumfield et al.
TRENDS IN ECOLOGY & EVOLUTION (2003)
HPV16/18 prevalence in cervical lesions/cancers and p53 genotypes in cervical cancer patients from India
D Saranath et al.
GYNECOLOGIC ONCOLOGY (2002)
Cisplatin and escalating doses of paclitaxel and epirubicin in advanced ovarian cancer. A phase I study
M Nardi et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2001)
Trim and fill: A simple funnel-plot-based method of testing and adjusting for publication bias in meta-analysis
S Duval et al.
BIOMETRICS (2000)
分享论文
